da Silva Jessé Lopes, Thuler Luiz Claudio Santos, de Melo Andréia Cristina
Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, 37 Andre Cavalcanti Street, 5th floor, Annex Building, 20231050, Rio de Janeiro, Brazil.
BMC Cancer. 2025 Jan 6;25(1):18. doi: 10.1186/s12885-024-13381-5.
Breast cancer (BC) has exhibited varied epidemiological trends based on distinct age categories. This research aimed to explore the incidence and mortality rates of BC within pre-defined age groups in the Brazilian population.
BC incidence trends were assessed from 2010 to 2015 using Brazilian Population-Based Cancer Registries, employing age-standardized ratios and annual average percentage change (AAPC). Hospital-Based Cancer Registries provided clinical and sociodemographic data from 2000 to 2019. Mortality data were obtained from the National Mortality Information System from 2000 to 2020. Three groups were compared: < 40, 40-69, and ≥ 70 years.
From 2010 to 2015, 205,966 new BC cases were recorded, with incidence rates of 7.1/100,000 for < 40, 156.5/100,000 for 40-69, and 247.5/100,000 for ≥ 70 years. The < 40 years group exhibited a significant increase in incidence rate (AAPC + 1.6; 95% CI: 1.0 to 2.2; p < 0.001). This age group also showed a higher proportion of black patients (53%, p < 0.001), alcohol consumption (20.5%, p < 0.001), proportion of patients treated at stages ≥ IIB (64.0%, p < 0.001), and a higher likelihood of receiving multiple treatment modalities (60.7%, p < 0.001). The ≥ 70 years group experienced a longer delay exceeding 60 days from diagnosis to treatment onset (54%, p < 0.001), while exhibiting a higher proportion of endocrine therapy utilization (45.3%, p < 0.01). Mortality rates increased across all subgroups, with the < 40 years group showing the most pronounced increase (AAPC + 1.8%; 95% CI: 1.6 to 2.1; p < 0.001).
These results highlight marked disparities in BC incidence, mortality rates, clinicopathological and sociodemographic characteristics between women under 40, and those in the 40-69 and ≥ 70 age groups in Brazil.
乳腺癌(BC)在不同年龄类别中呈现出不同的流行病学趋势。本研究旨在探讨巴西人群中预定义年龄组内乳腺癌的发病率和死亡率。
利用巴西基于人群的癌症登记处评估2010年至2015年乳腺癌的发病趋势,采用年龄标准化比率和年平均百分比变化(AAPC)。基于医院的癌症登记处提供了2000年至2019年的临床和社会人口学数据。死亡率数据来自2000年至2020年的国家死亡信息系统。比较了三个组:<40岁、40 - 69岁和≥70岁。
2010年至2015年,记录了205,966例新的乳腺癌病例,<40岁组的发病率为7.1/10万,40 - 69岁组为156.5/10万,≥70岁组为247.5/10万。<40岁组的发病率显著上升(AAPC +1.6;95%CI:1.0至2.2;p<0.001)。该年龄组黑人患者比例也更高(53%,p<0.001),饮酒率(20.5%,p<0.001),IIB期及以上阶段接受治疗的患者比例(64.0%,p<0.001),以及接受多种治疗方式的可能性更高(60.7%,p<0.001)。≥70岁组从诊断到开始治疗的延迟超过60天的时间更长(54%,p<0.001),同时内分泌治疗的使用率更高(45.3%,p<0.01)。所有亚组的死亡率均有所上升,<40岁组的上升最为显著(AAPC +1.8%;95%CI:1.6至2.1;p<0.001)。
这些结果突出了巴西40岁以下女性与40 - 69岁及≥70岁年龄组女性在乳腺癌发病率、死亡率、临床病理和社会人口学特征方面的显著差异。